Antonazzo, I., Bengala, C., Biganzoli, L., Mantovani, L., Michelotti, A., Cortesi, P. (2023). A BUDGET IMPACT ANALYSIS OF PERTUZUMAB, TRASTUZUMAB, AND CHEMOTHERAPY IN THE NEOADJUVANT SETTING FOR HER2-POSITIVE HIGH-RISK EARLY BREAST CANCER PATIENTS: INSIGHTS FROM THE TUSCANY REGIONAL HEALTH CARE SYSTEM PERSPECTIVE. VALUE IN HEALTH, 26(12), 121-121.
A BUDGET IMPACT ANALYSIS OF PERTUZUMAB, TRASTUZUMAB, AND CHEMOTHERAPY IN THE NEOADJUVANT SETTING FOR HER2-POSITIVE HIGH-RISK EARLY BREAST CANCER PATIENTS: INSIGHTS FROM THE TUSCANY REGIONAL HEALTH CARE SYSTEM PERSPECTIVE
Mantovani, LG;Cortesi, P
2023
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
